GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Range Low Price High Price Comment
30 days $143.66 $159.34 Wednesday, 17th Apr 2024 ALNY stock ended at $145.32. This is 0.95% less than the trading day before Tuesday, 16th Apr 2024. During the day the stock fluctuated 1.58% from a day low at $145.19 to a day high of $147.49.
90 days $143.52 $191.72
52 weeks $143.52 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
2024-03-12 $150.02 $150.02 $146.61 $146.65 683 362
2024-03-11 $150.24 $152.50 $148.88 $149.10 590 700
2024-03-08 $150.96 $152.88 $149.14 $149.82 636 951
2024-03-07 $150.42 $150.56 $149.24 $149.86 548 992
2024-03-06 $150.15 $150.24 $147.63 $149.66 502 771
2024-03-05 $148.94 $151.21 $147.52 $149.68 611 778
2024-03-04 $153.16 $154.85 $149.89 $150.04 908 502
2024-03-01 $150.90 $155.91 $150.00 $152.61 513 617
2024-02-29 $156.59 $157.52 $149.00 $151.09 1 457 393
2024-02-28 $156.56 $158.90 $153.94 $155.23 827 662
2024-02-27 $160.00 $161.31 $157.91 $159.00 612 777
2024-02-26 $156.49 $159.04 $153.94 $158.66 548 949
2024-02-23 $163.00 $163.01 $155.82 $157.65 1 197 664
2024-02-22 $154.47 $164.02 $154.22 $162.81 1 157 745
2024-02-21 $150.31 $155.38 $148.84 $154.74 3 546 302
2024-02-20 $146.98 $150.06 $146.11 $149.69 1 254 116
2024-02-16 $148.00 $150.93 $146.82 $147.00 1 883 389
2024-02-15 $150.00 $153.27 $143.52 $147.43 5 395 390
2024-02-14 $162.57 $164.63 $161.51 $164.15 842 370
2024-02-13 $164.89 $166.50 $160.84 $162.00 792 456
2024-02-12 $170.01 $171.55 $166.87 $169.34 782 410
2024-02-09 $169.49 $171.86 $168.54 $170.03 480 589
2024-02-08 $168.57 $170.25 $165.59 $169.50 882 012
2024-02-07 $172.55 $172.55 $167.43 $168.60 582 107
2024-02-06 $170.65 $173.18 $169.81 $172.18 1 430 391
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT